Amyris Engages FLG Partners
June 4, 2019 – Amyris, Inc. (NASDAQ: AMYR) announced today that FLG partner Jonathan Wolter has been engaged as interim Chief Financial Officer. Company press release. Company Form 8-K.
Read MoreImmersion Corp Engages FLG Partners
May 14, 2019 Immersion Corp (NASDAQ: IMMR) announced today that FLG partner, Cal Hoagland, has been engaged as interim Chief Financial Officer. Company Form 8k.
Read MoreHotel Tonight To Be Acquired by Airbnb
March 7, 2019 San Francisco, CA – Hotel Tonight announced today that it is to be acquired by AirBNB to expand the mobile home-sharing company’s hotel and travel offerings. FLG partner, Laureen DeBuono assisted Hotel Tonight as its Interim CFO to get the deal negotiated and executed. Read more here.
Read MoreOyster Point Raises $93 Million for Phase 3 Trials of Novel Treatment for Dry Eye Disease
PRINCETON, N.J., February 26, 2019 – FLG Partner’s client, Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company has announced a $93 million Series B financing. The round was co-led by Invus Opportunities and Flying L Partners in collaboration with Falcon Vision. Existing investors New Enterprise Associates (NEA) and…Read More
Read MoreCortexyme Announces Key Leadership Appointments to Support Next Stage of Growth
FLG client, Cortexyme, a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s disease (AD) and other degenerative disorders, announced effective January 2019, two key leadership appointments. Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime…Read More
Read More
Recent News
